To identify potent antiviral innate immune agonists, researchers screened a panel of 75 microbial ligands that activate diverse signaling pathways and identified cyclic dinucleotides, canonical STING agonists, as antiviral.
[Science Immunology]
6445212 MDVBQLPE items 1 apa 0 default asc 1 162374 https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
%7B%22status%22%3A%22success%22%2C%22updateneeded%22%3Afalse%2C%22instance%22%3A%22zotpress-612f9fce9d138411cc693479f71bbdf0%22%2C%22meta%22%3A%7B%22request_last%22%3A0%2C%22request_next%22%3A0%2C%22used_cache%22%3Atrue%7D%2C%22data%22%3A%5B%7B%22key%22%3A%22MDVBQLPE%22%2C%22library%22%3A%7B%22id%22%3A6445212%7D%2C%22meta%22%3A%7B%22creatorSummary%22%3A%22Li%20et%20al.%22%2C%22parsedDate%22%3A%222021-05-18%22%2C%22numChildren%22%3A2%7D%2C%22bib%22%3A%22%3Cdiv%20class%3D%5C%22csl-bib-body%5C%22%20style%3D%5C%22line-height%3A%202%3B%20padding-left%3A%201em%3B%20text-indent%3A-1em%3B%5C%22%3E%5Cn%20%20%3Cdiv%20class%3D%5C%22csl-entry%5C%22%3ELi%2C%20M.%2C%20Ferretti%2C%20M.%2C%20Ying%2C%20B.%2C%20Descamps%2C%20H.%2C%20Lee%2C%20E.%2C%20Dittmar%2C%20M.%2C%20Lee%2C%20J.%20S.%2C%20Whig%2C%20K.%2C%20Kamalia%2C%20B.%2C%20Dohnalov%26%23xE1%3B%2C%20L.%2C%20Uhr%2C%20G.%2C%20Zarkoob%2C%20H.%2C%20Chen%2C%20Y.-C.%2C%20Ramage%2C%20H.%2C%20Ferrer%2C%20M.%2C%20Lynch%2C%20K.%2C%20Schultz%2C%20D.%20C.%2C%20Thaiss%2C%20C.%20A.%2C%20Diamond%2C%20M.%20S.%2C%20%26amp%3B%20Cherry%2C%20S.%20%282021%29.%20Pharmacological%20activation%20of%20STING%20blocks%20SARS-CoV-2%20infection.%20%3Ci%3EScience%20Immunology%3C%5C%2Fi%3E%2C%20%3Ci%3E6%3C%5C%2Fi%3E%2859%29.%20%3Ca%20href%3D%27https%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fsciimmunol.abi9007%27%3Ehttps%3A%5C%2F%5C%2Fdoi.org%5C%2F10.1126%5C%2Fsciimmunol.abi9007%3C%5C%2Fa%3E%20%3Ca%20title%3D%27Cite%20in%20RIS%20Format%27%20class%3D%27zp-CiteRIS%27%20href%3D%27https%3A%5C%2F%5C%2Fwww.stemcellsciencenews.com%5C%2Fwp-content%5C%2Fplugins%5C%2Fzotpress%5C%2Flib%5C%2Frequest%5C%2Frequest.cite.php%3Fapi_user_id%3D6445212%26amp%3Bitem_key%3DMDVBQLPE%27%3ECite%3C%5C%2Fa%3E%20%3C%5C%2Fdiv%3E%5Cn%3C%5C%2Fdiv%3E%22%2C%22data%22%3A%7B%22itemType%22%3A%22journalArticle%22%2C%22title%22%3A%22Pharmacological%20activation%20of%20STING%20blocks%20SARS-CoV-2%20infection%22%2C%22creators%22%3A%5B%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Minghua%22%2C%22lastName%22%3A%22Li%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Max%22%2C%22lastName%22%3A%22Ferretti%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Baoling%22%2C%22lastName%22%3A%22Ying%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22H%5Cu00e9l%5Cu00e8ne%22%2C%22lastName%22%3A%22Descamps%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Emily%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Mark%22%2C%22lastName%22%3A%22Dittmar%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Jae%20Seung%22%2C%22lastName%22%3A%22Lee%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kanupriya%22%2C%22lastName%22%3A%22Whig%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Brinda%22%2C%22lastName%22%3A%22Kamalia%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Lenka%22%2C%22lastName%22%3A%22Dohnalov%5Cu00e1%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Giulia%22%2C%22lastName%22%3A%22Uhr%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Hoda%22%2C%22lastName%22%3A%22Zarkoob%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Yu-Chi%22%2C%22lastName%22%3A%22Chen%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Holly%22%2C%22lastName%22%3A%22Ramage%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Marc%22%2C%22lastName%22%3A%22Ferrer%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Kristen%22%2C%22lastName%22%3A%22Lynch%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22David%20C.%22%2C%22lastName%22%3A%22Schultz%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Christoph%20A.%22%2C%22lastName%22%3A%22Thaiss%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Michael%20S.%22%2C%22lastName%22%3A%22Diamond%22%7D%2C%7B%22creatorType%22%3A%22author%22%2C%22firstName%22%3A%22Sara%22%2C%22lastName%22%3A%22Cherry%22%7D%5D%2C%22abstractNote%22%3A%22Severe%20acute%20respiratory%20syndrome%20coronavirus%202%20%28SARS-CoV-2%29%20has%20caused%20a%20global%20pandemic%2C%20resulting%20millions%20of%20infections%20and%20deaths%20with%20few%20effective%20interventions%20available.%20Here%2C%20we%20demonstrate%20that%20SARS-CoV-2%20evades%20interferon%20%28IFN%29%20activation%20in%20respiratory%20epithelial%20cells%2C%20resulting%20in%20a%20delayed%20response%20in%20bystander%20cells.%20Since%20pretreatment%20with%20IFNs%20can%20block%20viral%20infection%2C%20we%20reasoned%20that%20pharmacological%20activation%20of%20innate%20immune%20pathways%20could%20control%20SARS-CoV-2%20infection.%20To%20identify%20potent%20antiviral%20innate%20immune%20agonists%2C%20we%20screened%20a%20panel%20of%2075%20microbial%20ligands%20that%20activate%20diverse%20signaling%20pathways%20and%20identified%20cyclic%20dinucleotides%20%28CDNs%29%2C%20canonical%20STING%20agonists%2C%20as%20antiviral.%20Since%20CDNs%20have%20poor%20bioavailability%2C%20we%20tested%20the%20small%20molecule%20STING%20agonist%20diABZI%2C%20and%20found%20that%20it%20potently%20inhibits%20SARS-CoV-2%20infection%20of%20diverse%20strains%20including%20variants%20of%20concern%20%28B.1.351%29%20by%20transiently%20stimulating%20IFN%20signaling.%20Importantly%2C%20diABZI%20restricts%20viral%20replication%20in%20primary%20human%20bronchial%20epithelial%20cells%20and%20in%20mice%20in%20vivo.%20Our%20study%20provides%20evidence%20that%20activation%20of%20STING%20may%20represent%20a%20promising%20therapeutic%20strategy%20to%20control%20SARS-CoV-2.%5CnPharmacological%20activation%20of%20STING%20blocks%20SARS-CoV-2%20infection%20including%20variants%20of%20concern%20in%20vitro%20and%20in%20vivo.%5CnPharmacological%20activation%20of%20STING%20blocks%20SARS-CoV-2%20infection%20including%20variants%20of%20concern%20in%20vitro%20and%20in%20vivo.%22%2C%22date%22%3A%222021%5C%2F05%5C%2F18%22%2C%22language%22%3A%22en%22%2C%22DOI%22%3A%2210.1126%5C%2Fsciimmunol.abi9007%22%2C%22ISSN%22%3A%222470-9468%22%2C%22url%22%3A%22https%3A%5C%2F%5C%2Fimmunology.sciencemag.org%5C%2Fcontent%5C%2F6%5C%2F59%5C%2Feabi9007%22%2C%22collections%22%3A%5B%5D%2C%22dateModified%22%3A%222021-05-18T16%3A21%3A16Z%22%7D%7D%5D%7D
Li, M., Ferretti, M., Ying, B., Descamps, H., Lee, E., Dittmar, M., Lee, J. S., Whig, K., Kamalia, B., Dohnalová, L., Uhr, G., Zarkoob, H., Chen, Y.-C., Ramage, H., Ferrer, M., Lynch, K., Schultz, D. C., Thaiss, C. A., Diamond, M. S., & Cherry, S. (2021). Pharmacological activation of STING blocks SARS-CoV-2 infection. Science Immunology, 6(59). https://doi.org/10.1126/sciimmunol.abi9007 Cite